Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Change in Cash: 2011-2024

Historic Change in Cash for Abeona Therapeutics (ABEO) over the last 14 years, with Dec 2024 value amounting to $8.9 million.

  • Abeona Therapeutics' Change in Cash fell 331.29% to -$80.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.2 million, marking a year-over-year increase of 509.75%. This contributed to the annual value of $8.9 million for FY2024, which is 3370.31% up from last year.
  • According to the latest figures from FY2024, Abeona Therapeutics' Change in Cash is $8.9 million, which was up 3,370.31% from $256,000 recorded in FY2023.
  • In the past 5 years, Abeona Therapeutics' Change in Cash ranged from a high of $25.3 million in FY2021 and a low of -$116.8 million during FY2020.
  • Moreover, its 3-year median value for Change in Cash was $256,000 (2023), whereas its average is -$5.0 million.
  • Its Change in Cash has fluctuated over the past 5 years, first tumbled by 205.17% in 2020, then spiked by 3,370.31% in 2024.
  • Yearly analysis of 5 years shows Abeona Therapeutics' Change in Cash stood at -$116.8 million in 2020, then surged by 121.63% to $25.3 million in 2021, then crashed by 196.10% to -$24.3 million in 2022, then soared by 101.05% to $256,000 in 2023, then spiked by 3,370.31% to $8.9 million in 2024.